RxDoctor Payments Data

Harris Hawk, MD

Vascular & Interventional Radiology · Chattanooga, TNNPI 1114131588

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,481 of the $11,741 with a category attached, or 63.7%. 17 manufacturers reported payments, led by Balt USA, LLC at 40.6% of the total. Reporting peaked in 2019 at $5,644 and has fallen 90.9% since, to $512 in 2025.

$11,741in general payments, 2019–2025

Across 179 payments — averaging $65.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Balt USA, LLC$5K
  • Imperative Care, Inc$4K
  • Stryker$1K
  • Johnson & Johnson$594
  • Medtronic$482
  • Penumbra, Inc.$448
  • plus $426 from 11 others
$85,494in research payments, 2019–2025

Across 27 payments — averaging $3166.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$66K
  • Medtronic$11K
  • Medical Device Business Services, Inc.$9K

What the payments were for

  • Consulting fees$4,26036%
  • Food & beverage$7,48164%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,741 in reported general payments places this provider in the 75th percentile of 76 vascular & interventional radiology providers in Tennessee.

See all vascular & interventional radiology providers in Tennessee

Medicare billing

Part B allowed, 2024
$152,986
Medicare patients
1,866
Services billed
2,730

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor49$24,455
ClopidogrelClopidogrel Bisulfate62$247

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Chattanooga

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →